40 million people live with HIV globally, and that number continues to rise. While therapies exist to reduce the amount of HIV in a patient’s body and, in turn, reduce HIV symptoms, there remains no cure. Engineering better drugs and eventually a cure depends on our ability to answer foundational questions like: How does HIV invade and replicate in host cells?
Bursting HIV’s bubble: A new workflow to study HIV-1 genome-containing capsids
